On Monday, Organogenesis Holdings Inc (NASDAQ: ORGO) was 4.35% up from the session before settling in for the closing price of $4.37. A 52-week range for ORGO has been $2.28 – $6.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 766.67%. With a float of $64.15 million, this company’s outstanding shares have now reached $126.85 million.
In an organization with 869 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 74.89%, operating margin of -5.27%, and the pretax margin is -5.29%.
Organogenesis Holdings Inc (ORGO) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Organogenesis Holdings Inc stocks. The insider ownership of Organogenesis Holdings Inc is 49.43%, while institutional ownership is 53.44%. The most recent insider transaction that took place on Jun 05 ’25, was worth 413,625. In this transaction Chief Admin. and Legal Officer of this company bought 142,379 shares at a rate of $2.91, taking the stock ownership to the 837,437 shares. Before that another transaction happened on Jun 04 ’25, when Company’s Chief Admin. and Legal Officer bought 100,863 for $2.82, making the entire transaction worth $284,716. This insider now owns 695,058 shares in total.
Organogenesis Holdings Inc (ORGO) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 766.67% per share during the next fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
You can see what Organogenesis Holdings Inc (ORGO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.67. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.15, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach 0.20 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
Let’s dig in a bit further. During the last 5-days, its volume was 1.2 million. That was inferior than the volume of 1.56 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 71.35%.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 47.56%, which indicates a significant decrease from 87.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.27 in the past 14 days, which was lower than the 0.32 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.51, while its 200-day Moving Average is $3.74.
